Peng H - Search Results

1

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.

Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, Rangarajan ES, Pan A, Vanderheiden A, Suthar MS, Li W, Izard T, Rader C, Farzan M, Choe H. Zhang L, et al. Among authors: peng h. Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4. Nat Commun. 2020. PMID: 33243994 Free PMC article.

2

Recognition of antigen-specific B-cell receptors from chronic lymphocytic leukemia patients by synthetic antigen surrogates.

Sarkar M, Liu Y, Morimoto J, Peng H, Aquino C, Rader C, Chiorazzi N, Kodadek T. Sarkar M, et al. Among authors: peng h. Chem Biol. 2014 Dec 18;21(12):1670-9. doi: 10.1016/j.chembiol.2014.10.010. Epub 2014 Nov 26. Chem Biol. 2014. PMID: 25467125 Free PMC article.

3

Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates.

Sarkar M, Liu Y, Qi J, Peng H, Morimoto J, Rader C, Chiorazzi N, Kodadek T. Sarkar M, et al. Among authors: peng h. J Biol Chem. 2016 Apr 1;291(14):7558-70. doi: 10.1074/jbc.M115.701656. Epub 2016 Feb 5. J Biol Chem. 2016. PMID: 26851280 Free PMC article.

4

From rabbit antibody repertoires to rabbit monoclonal antibodies.

Weber J, Peng H, Rader C. Weber J, et al. Among authors: peng h. Exp Mol Med. 2017 Mar 24;49(3):e305. doi: 10.1038/emm.2017.23. Exp Mol Med. 2017. PMID: 28336958 Free PMC article. Review.

5

Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1.

Qi J, Li X, Peng H, Cook EM, Dadashian EL, Wiestner A, Park H, Rader C. Qi J, et al. Among authors: peng h. Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):E5467-E5476. doi: 10.1073/pnas.1719905115. Epub 2018 May 29. Proc Natl Acad Sci U S A. 2018. PMID: 29844189 Free PMC article.

6

A Sortase A Programmable Phage Display Format for Improved Panning of Fab Antibody Libraries.

Wilson HD, Li X, Peng H, Rader C. Wilson HD, et al. Among authors: peng h. J Mol Biol. 2018 Oct 19;430(21):4387-4400. doi: 10.1016/j.jmb.2018.09.003. Epub 2018 Sep 11. J Mol Biol. 2018. PMID: 30213726 Free PMC article.

7

Chemically Programmable and Switchable CAR-T Therapy.

Qi J, Tsuji K, Hymel D, Burke TR Jr, Hudecek M, Rader C, Peng H. Qi J, et al. Among authors: peng h. Angew Chem Int Ed Engl. 2020 Jul 13;59(29):12178-12185. doi: 10.1002/anie.202005432. Epub 2020 May 18. Angew Chem Int Ed Engl. 2020. PMID: 32329959 Free PMC article.

8

Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.

Mou H, Quinlan BD, Peng H, Guo Y, Peng S, Zhang L, Davis-Gardner ME, Gardner MR, Crynen G, Voo ZX, Bailey CC, Alpert MD, Rader C, Choe H, Farzan M. Mou H, et al. Among authors: peng s, peng h. bioRxiv [Preprint]. 2020 Jun 30:2020.06.29.178459. doi: 10.1101/2020.06.29.178459. bioRxiv. 2020. PMID: 32637954 Free PMC article. Updated. Preprint.

9

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.

Mou H, Quinlan BD, Peng H, Liu G, Guo Y, Peng S, Zhang L, Davis-Gardner ME, Gardner MR, Crynen G, DeVaux LB, Voo ZX, Bailey CC, Alpert MD, Rader C, Gack MU, Choe H, Farzan M. Mou H, et al. Among authors: peng s, peng h. PLoS Pathog. 2021 Apr 9;17(4):e1009501. doi: 10.1371/journal.ppat.1009501. eCollection 2021 Apr. PLoS Pathog. 2021. PMID: 33836016 Free PMC article.

10

ROR1-targeting switchable CAR-T cells for cancer therapy.

Peng H, Nerreter T, Mestermann K, Wachter J, Chang J, Hudecek M, Rader C. Peng H, et al. Oncogene. 2022 Aug;41(34):4104-4114. doi: 10.1038/s41388-022-02416-5. Epub 2022 Jul 20. Oncogene. 2022. PMID: 35859167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,514 results

Search Page